ReviewNanomedicine (London, England)2025
Nanomaterials and nanotechnology in otolaryngology: a narrative review.
Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We reviewed usage of nanomaterials and nanotechnology in otolaryngology. The literature search in this narrative review used Google, Google Scholar, PubMed, EBSCO, Proquest Central, Proquest Central, Web of Science and Scopus at Kırıkkale University. We searched for "Nanomaterials," "nanotechnology," "otolaryngology," "rhinology," "laryngology," "head and neck," and "otology" between 2020 and 2025. Clinical trials, retrospective studies, reviews and experimental studies were included into this paper. Nanomaterials and nanoparticles (NPs) have the potential to transform medical care. NPs can bypass traditional therapeutic barriers because of their small size. Potential applications of nanoparticles include drug delivery and cell-to-cell communication. In rhinology, Amphotericin B was delivered using gelatine nanoparticles without significant nephrotoxicity or hematological side effects. In cases ranging from obvious vascular bleeding to cerebral hemorrhage, N-hydroxysulfosuccinimide formed a nanofiber barrier that achieved rapid and complete hemostasis. In medical nanotechnology, cancer theranostics is currently a leading field. In otology, nanotechnology is used for the cochlear implant. Creating nanofibrous scaffolds with synthetic, biomimetic extracellular matrix analogs holds great promise for regenerative medicine. Advantages of nanotechnology over conventional methods are targeted delivery, reduced side effects, biosafety and scalable production in the fields of rhinology, laryngology, head & neck, and otology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.